Patents by Inventor Carsten E. Stidsen

Carsten E. Stidsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzothienopyrazinedione compounds and their preparation and use
    Patent number: 5182279
    Abstract: Novel [1]benzothieno[2,3-b]pyrazine-2,3(1H,4H)-diones or tautomeric forms thereof of the general formula (I) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 independently represent hydrogen, halogen, alkyl, alkoxy or trifluoromethyl.The compounds are useful for treating a central nervous system ailment associated with the NMDA receptor-associated glycine site.
    Type: Grant
    Filed: April 18, 1991
    Date of Patent: January 26, 1993
    Assignee: Novo Nordisk A/S
    Inventors: Anker S. Jorgensen, Carsten E. Stidsen, Peter Faarup, Frederik C. Gronvald, Flemming E. Nielsen
  • Quinoxaline-2,3-dione compounds and their preparation and use
    Patent number: 5166155
    Abstract: 1-carboxyalkylquinoxaline-2,3(1H,4H)-dione compounds or tautomeric forms thereof of the formula ##STR1## wherein R represents hydrogen, C.sub.1-6 -alkyl, including branched chains, or aralkyl and n represents the number from 0 to 5;R.sup.4 represents hydrogen or hydroxy;R.sup.5, R.sup.6, R.sup.7 and R.sup.8 independently represent hydrogen, nitro, halogen, alkoxy, aryloxy, aralkoxy, C.sub.1-6 -alkyl including branched chains, or aryl;R.sup.9 represents hydrogen, lower alkyl, or aryl;R.sup.10 represents hydrogen, or alkyl.The compounds are useful in the treatment of neurological and psychiatric diseases.
    Type: Grant
    Filed: March 12, 1991
    Date of Patent: November 24, 1992
    Assignee: Novo Nordisk A/S
    Inventors: Anker S. Jorgensen, Carsten E. Stidsen, Peter Faarup, Frederik S. Gronvald